← All Aptorum Group LTD filings

Aptorum Group LTD 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NASDAQ
APM
Aptorum Group LTD
20-F: Aptorum Group Faces Going Concern Doubt Amid R&D Focus & Merger
Aptorum Group's latest annual report highlights a net loss, negative working capital, and substantial doubt about its ability to continue as a going concern, despite focusing on lead R&D projects and a proposed merger with DiamiR Biosciences.
NASDAQ
APM
Aptorum Group LTD
20-F: Aptorum Group Limited Reports Annual Results for Fiscal Year 2024
Aptorum Group Limited announces its financial results for the year ended December 31, 2024, highlighting R&D focus and ongoing clinical trials.
NASDAQ
APM
Aptorum Group LTD
20-F: Aptorum Group Limited Announces Executive Changes and Files Annual Report on Form 20-F
Aptorum Group Limited files its annual report on Form 20-F, detailing executive changes and financial performance for the year ended December 31, 2023.